Latest news with #Argonaut
Yahoo
08-07-2025
- Science
- Yahoo
Europe's Moon Race Begins: French-Built Luna Rover Unveiled In Bold Bid To Conquer The Lunar South Pole By 2030
This French-built lunar rover is hoping to spearhead Europe's ambitions in space. Developed by Venturi Space, MONA LUNA aims to land a fully European vehicle on the Moon by 2030. A response to growing demands for European autonomy in lunar exploration, MONA LUNA is a major milestone for the EU's Moon mission plans. Venturi Space France leads the project, from assembling batteries to testing systems, all from their Toulouse facility. The rover will launch on the European Ariane 6.4 rocket and land via the Argonaut lunar lander. MONA LUNA is fully electric, powered by solar panels and three high-performance batteries, capable of operating autonomously on the Moon. With a top speed of 20 km/h, MONA LUNA is designed to survive lunar nights and carry scientific payloads. The rover includes a robotic arm and could even rescue stranded astronauts in emergency situations. Gildo Pastor, President of Venturi Space, sees MONA LUNA as Europe's entry into the next frontier of space exploration.
Yahoo
19-06-2025
- Science
- Yahoo
Venturi Space Shows Off Its Pitch for a New Lunar Lander
Monaco-based Venturi Space has debuted a new design for a next-generation lunar rover that it's calling Mona Luna. It's a pitch that it hopes the European Space Agency (ESA) will pick up during its ministerial conference later this year. It includes a new deformable wheel design and a sleek, futuristic look, with instruments held near the center to protect against harsh moon temperature swings throughout the day/night cycle. The Venturi Space pitch is that the ESA already has a lunar launch vehicle in the Ariane 6, and a lunar lander in the Argonaut for future payload delivery to the Moon. But what it doesn't have, though, is a lunar rover, and Venturi wants to be the company to provide it, as reports. Mona Luna is a next-generation rover design that looks sleek and futuristic, eschewing the gangly, many-limbed rovers we're used to seeing exploring Mars in recent years. That's because the Mona Luna keeps most of its instruments internally to better protect them against the extreme elements and temperature swings that can be experienced on the moon's surface. In the above concept video, Venturi shows the rover opening its back panel to reveal a number of modular sensors and tools, which the articulating arm can attach and detach to and from at will. That allows a single arm to provide the full functionality of the rover, cutting back on overall costs and weight in the design. It also allows each instrument to have the same level of flexible control. Another technology Venturi is pioneering for this design is its deformable wheels. These wheels are capable of handling extreme temperature swings from -240 degrees C to 130 degrees C while retaining the same strength and support so that the rover can continue to operate even in the lunar south pole. This hyper-mobile wheel design should also let the rover traverse more demanding surface conditions, letting it travel where previous rovers would be unable to even attempt. Although the rover's weight is 1650 pounds, with payloads, it could reach as high as 4,400 pounds. The wheels are designed to handle that while still maintaining the ability to reach nine miles per hour or up to 12 miles per hour with lighter payloads. If Venturi is successful in convincing the ESA to provide some of its budget for a rover contract, it will be able to show proof of its concepts before a potential 2030+ mission. The wheel technologies are being used in the next generation of NASA's own lunar vehicle, the Flex Rover, currently under development at California-based Astrolab. That vehicle is expected to launch for a lunar south pole mission sometime in 2026 or 2027.
Business Wire
18-06-2025
- Business
- Business Wire
Cytiva and Argonaut Collaborate to Expand Reagent Lyophilization Manufacturing in EU and US
AMERSHAM, United Kingdom & CARLSBAD, Calif.--(BUSINESS WIRE)--Cytiva and Argonaut Manufacturing Services Inc., 'Argonaut,' have established a contract manufacturing agreement to enhance reagent stabilization services and lyophilization capabilities for diagnostic assay developers globally. Lyophilization and reagent stabilization provides substantial benefits to both diagnostic companies and their customers including cost reduction, elimination of cold-chain logistics, and extended shelf-life. Additionally, these approaches are favourable for environmental stewardship (e.g. ESG initiatives) as they reduce emissions and carbon footprint. Lyophilization may also assist organizations in addressing the new ISO 9001 guidance on climate change. The collaboration will help diagnostic assay developers to access critical support services from the combined capabilities of both companies, gain the advantages of lyophilization capabilities at scale and access manufacturing facilities in both Europe and the US benefitting from: Reduced shipping costs and overall cost of goods reduction Shorter project timelines speeding up commercialization of tests Reduced emissions and carbon footprint promoting sustainable business practices 'Working together with Cytiva notably improves our manufacturing capacity, improving the service offered to our customers especially in the UK/EU marketplace. Putting our customer needs first is at the center of everything we do,' commented Stacy Sutton, General Manager of Life Sciences at Argonaut Manufacturing Services, Inc. Gabriel Fernandez de Pierola, General Manager of Diagnostic and Genomic Solutions at Cytiva, comments 'Feedback from our customers shows a preference towards local manufacturing for lyophilization projects and working with Argonaut to provide cGMP level manufacturing further helps to address evolving customer needs in the lyophilization space.' The partnership is anticipated to positively impact diagnostic assay development teams with immediate effect. About Cytiva At Cytiva, our mission is to advance and accelerate the development of therapeutics. With 15,000 associates in more than 40 countries, we're driven to use our expertise and talent to achieve better flexibility, capacity, and efficiency for our customers. Our broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides critical support from discovery to delivery, for customers spanning researchers, emerging biotech, large-scale biopharma and contract manufacturers. Learn more at About Argonaut Argonaut Manufacturing Services, Inc. is an FDA-registered cGMP contract manufacturing organization (CMO) dedicated to providing custom manufacturing and supply chain solutions for biopharmaceutical and diagnostic companies. Aseptic drug fill/finish features state-of-the-art automated equipment for high yield filling of sterile injectable drugs including biologics, peptides, small molecule, and vaccines. Diagnostic manufacturing includes proprietary lyophilization technology and a spectrum of kitting capabilities. Projects are supported with full analytical quality control services including warehousing and global shipping logistics. Serving innovators in the life science, molecular diagnostics, and biopharma industries, Argonaut provides a wide range of flexible solutions for diverse outsourcing needs. Learn more at
Yahoo
18-06-2025
- Business
- Yahoo
Cytiva and Argonaut Collaborate to Expand Reagent Lyophilization Manufacturing in EU and US
Global Diagnostic Companies to Benefit with Faster Development & Manufacturing AMERSHAM, United Kingdom & CARLSBAD, Calif., June 18, 2025--(BUSINESS WIRE)--Cytiva and Argonaut Manufacturing Services Inc., "Argonaut," have established a contract manufacturing agreement to enhance reagent stabilization services and lyophilization capabilities for diagnostic assay developers globally. Lyophilization and reagent stabilization provides substantial benefits to both diagnostic companies and their customers including cost reduction, elimination of cold-chain logistics, and extended shelf-life. Additionally, these approaches are favourable for environmental stewardship (e.g. ESG initiatives) as they reduce emissions and carbon footprint. Lyophilization may also assist organizations in addressing the new ISO 9001 guidance on climate change. The collaboration will help diagnostic assay developers to access critical support services from the combined capabilities of both companies, gain the advantages of lyophilization capabilities at scale and access manufacturing facilities in both Europe and the US benefitting from: Reduced shipping costs and overall cost of goods reduction Shorter project timelines speeding up commercialization of tests Reduced emissions and carbon footprint promoting sustainable business practices "Working together with Cytiva notably improves our manufacturing capacity, improving the service offered to our customers especially in the UK/EU marketplace. Putting our customer needs first is at the center of everything we do," commented Stacy Sutton, General Manager of Life Sciences at Argonaut Manufacturing Services, Inc. Gabriel Fernandez de Pierola, General Manager of Diagnostic and Genomic Solutions at Cytiva, comments "Feedback from our customers shows a preference towards local manufacturing for lyophilization projects and working with Argonaut to provide cGMP level manufacturing further helps to address evolving customer needs in the lyophilization space." The partnership is anticipated to positively impact diagnostic assay development teams with immediate effect. About Cytiva At Cytiva, our mission is to advance and accelerate the development of therapeutics. With 15,000 associates in more than 40 countries, we're driven to use our expertise and talent to achieve better flexibility, capacity, and efficiency for our customers. Our broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides critical support from discovery to delivery, for customers spanning researchers, emerging biotech, large-scale biopharma and contract manufacturers. Learn more at About Argonaut Argonaut Manufacturing Services, Inc. is an FDA-registered cGMP contract manufacturing organization (CMO) dedicated to providing custom manufacturing and supply chain solutions for biopharmaceutical and diagnostic companies. Aseptic drug fill/finish features state-of-the-art automated equipment for high yield filling of sterile injectable drugs including biologics, peptides, small molecule, and vaccines. Diagnostic manufacturing includes proprietary lyophilization technology and a spectrum of kitting capabilities. Projects are supported with full analytical quality control services including warehousing and global shipping logistics. Serving innovators in the life science, molecular diagnostics, and biopharma industries, Argonaut provides a wide range of flexible solutions for diverse outsourcing needs. Learn more at View source version on Contacts Argonaut Media Contact Name: Billy BurrisEmail: billy@ Phone: 609-458-8662
Fast Company
12-06-2025
- Automotive
- Fast Company
Ram Trucks fires up a near-perfect brand apology ad
Last year, when Ram Trucks parent company Stellantis announced it would discontinue the automaker's popular Hemi V-8 engine for its Ram 1500 full-size pickup truck beginning this summer, its fans were upset—to say the least. 'When Ram made the decision to discontinue production of the iconic Hemi V-8, the internet erupted, and lifelong loyalists voiced their outrage across social media,' says Lindsay Fifelski, head of Ram brand advertising. 'We knew we couldn't market our way around this moment; we had to meet it head-on.' In the interim 12 months since the announcement, then-CEO Carlos Tavares stepped down from Stellantis. Then last week, the company announced the corporate version of 'Never mind!'—and the Hemi was back before it even left. To double down on their message, Ram Trucks created a new commercial starring its CEO Tim Kuniskis—and in it he admits the company made a mistake. Sales were down by more than 18% year over year in 2024, but Kuniskis told CNBC that he expects Hemi to represent 25% to 40% of the Ram 1500 pickup trucks' sales this year. Created with the ad agency Argonaut, the new spot was shot entirely with practical effects. It features Kuniskis himself behind the wheel of the truck, doing doughnuts, drifting, and taking a few hot laps on a NASCAR track. One of Kuniskis's first lines in the ad is: 'We own it. We got it wrong. And we're fixing it.' It's a simple, textbook brand apology, creatively combined with the kind of pep talk aimed to get brand fans hyped for what's next. The Ram apology ad is part of a growing—and refreshing—trend of brands increasingly having the cajones to own their mistakes and be upfront about it. Last year, I outlined the five types of brand apologies. Both Bumble and Apple were examples of what I categorized as 'The Genuine Apology.' This week, Ram Trucks joined the club. Make it right While a clear, unequivocal apology often feels like the most logical response to a mistake or to genuine brand fan anger, it's not what brands are intuitively built to do. Deflect, distract, and avoid are too often on the menu. Argonaut founder and chief creative officer Hunter Hindman knew the right answer here; he just had to convince his client. 'We all knew the best solution would be to put Tim in the hot seat, front and center,' Hindman says. 'No corporate gloss. No hiding behind brand spin. Just a man, a machine, and a promise to make it right. And to Tim's credit, he didn't blink.' Kuniskis says it wasn't a tough decision to admit the mistake. The brand knew almost instantly after last year's announcement that it had a problem. A 2022 study from Forrester found that 41% of consumers would return to a brand that concedes to making a mistake and apologizes for it. 'Our customers told us loud and clear how—and I'll say this lightly— 'displeased' they were with our decision to get rid of the Hemi V-8,' he says. 'You only had to go on to social media to see how they were feeling. Betrayed. We know that truck buyers are very loyal to their brand, and once you lose them, you have to fight tooth and nail to get them back. It was almost immediately clear that we had to right the wrong.'
